
Test
Influenza
©2007 MDtravelhealth.com. All Rights Reserved. Terms of Use.
Influenza is a viral infection characterized by fever, chills, malaise, headaches, body aches, and cough, sometimes complicated by pneumonia, which may be life-threatening. All age groups may be affected, but severe illness is more common in the elderly and in those with chronic illnesses such as asthma, diabetes, kidney failure, and heart disease. Influenza occurs in annual epidemics from November to March in the temperate regions of the Northern Hemisphere and from April to September in the temperate regions of the Southern Hemisphere. However, travelers in large groups, especially those on cruise ships, may be at risk year-round, due to exposure to influenza viruses carried by persons from other parts of the world. Influenza is reported sporadically throughout the year in the tropics.
Because influenza may cause significant distress during foreign travel, because medical care may be difficult to obtain while abroad, and because the symptoms of influenza, which are non-specific, may be confused with those of other illnesses, influenza vaccine should be seriously considered for all international travelers at risk, i.e. those traveling to the Northern Hemisphere between November and March, those traveling to the Southern Hemisphere between April and September, and those traveling on cruise ships or to the tropics at any time. Influenza vaccine is strongly recommended for all those over age 50 and for those with chronic medical conditions such as diabetes, emphysema, asthma, or heart disease. The vaccine should be given at least two weeks before departure.
Twice each year, before influenza season in the Northern and Southern Hemispheres, the World Health Organization makes recommendations for vaccine composition, depending upon which strains appear most likely to cause outbreaks. If influenza vaccine for the Southern Hemisphere is not available, the vaccine for the preceding influenza season in the Northern Hemisphere, if obtainable, is the recommended alternative. Fortunately, for the year 2007, the vaccine recommended for the Southern Hemisphere is the same as that recommended for the Northern Hemisphere the preceding winter.
The most frequent side-effect of influenza vaccine is mild discomfort at the injection site. Fever, malaise, and body aches may occur, but are typically mild. Severe reactions, generally allergic, are rare. Because the viruses in the vaccine are inactivated, influenza vaccine cannot cause influenza. Influenza vaccine should not be given to anyone allergic to eggs or in the first trimester of pregnancy.
A new nasal-spray flu vaccine was licensed in the United States in 2003. Unlike the injectable flu vaccine, it contains live, weakened flu virus. It includes the same strains of influenza as the injectable vaccine and appears to have comparable efficacy. In the United States, the nasal-spray vaccine is only approved for use in healthy people between the ages of 5 and 49.
Two new drugs are available to treat influenza: oseltamivir (Tamiflu) and zanamivir (Relenza) (PDF). Oseltamivir is available as 75-mg capsules, given twice daily by mouth for five days. The most common side-effects are nausea and vomiting, which are generally mild. Zanamivir is a dry powder prepared as an oral inhaler, given two inhalations twice daily for five days. Zanamivir may cause an exacerbation of asthma or chronic obstructive lung disease; it should be given with caution to persons suffering from those diseases. Two older anti-influenza drugs, amantadine and rimantadine, are also available, but are only effective against influenza A viruses, as opposed to oseltamivir and zanamivir, which are active against both influenza A and B.
From the World Health Organization
FluNet (Global Influenza Surveillance Network)
Influenza fact sheet
Influenza vaccine
Influenza vaccines - WHO position paper (PDF)
Influenza vaccine manufacturers
Influenza in the world 1 October 2000 - 30 September 2001 (PDF)
From the Centers for Disease Control (CDC)
Influenza Home Page
Influenza
Influenza: The Disease
Influenza: Prevention and Control
Influenza: Questions and Answers
Influenza: Vaccine Information
Antiviral Drugs for Influenza
Influenza B Virus Outbreak on a Cruise Ship --- Northern Europe, 2000
Chiefly for physicians:
Update: influenza activity -- United States and worldwide, 2006/2007 season, and composition of the 2007/2008 influenza vaccineMMWR August 10, 2007/Vol. 56(31): 789-94
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
MMWR July 29, 2007/Vol. 56:1-54
Neuraminidase Inhibitors for Treatment of Influenza A and B Infections (MMWR December 17, 1999/Vol. 48/RR-14
Influenza vaccines(PDF)
From Health Canada
Influenza and Travel: Cruise Ships and Land-based Tours
Supplementary Statement for the 2002-2003 Influenza Season:Update on Oculo-Respiratory Syndrome in Association with Influenza Vaccination
From the U.K. Health Protection Agency
Influenza
Frequently asked questions on flu
Weekly reports for the influenza season 2003-2004
From Emerging Infectious Diseases
Special Issue: Influenza
- Back to Infectious Diseases -
|